GlassScriptPhysician profile
Geoffrey Kozak
NPI 1275929309
$1,557.99
in general payments reported to CMS, 2019-2025
13 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $248 · 2023: $37.21 · 2024: $792 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,309.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $263.60 | 2024-2025 | Restrata Wound Matrix |
| Abbvie INC. | $234.06 | 2024-2025 | |
| Tela Bio, INC. | $151.12 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $140.40 | 2022-2023 | Pico 7 |
| Kci USA, INC. | $128.15 | 2022 | |
| Rti Surgical, INC | $126.86 | 2024 | |
| Polynovo North America LLC | $124.78 | 2024 | Novosorb Btm |
| Kerecis Limited | $107.73 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Axogen | $96.56 | 2024 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector |
| Motiva USA, LLC | $92.54 | 2025 | |
| Integra Lifesciences Corporation | $38.56 | 2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Urgo Medical North America, LLC | $36.67 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Endo Pharmaceuticals INC. | $16.96 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geoffrey Kozak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.